Inhaled ZYESAMI (aviptadil acetate) for the treatment of severe COVID-19
SARS-CoV 2 · ARDS · Acute Lung Injury
Enrolment: 144 · Results not recorded
Loading the evidence…
Hormone
1 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
SARS-CoV 2 · ARDS · Acute Lung Injury
Enrolment: 144 · Results not recorded
Acute Respiratory Distress Syndrome · COVID 19 · Respiratory Failure
Enrolment: 54 · Results not recorded
Covid19
Enrolment: 80 · Results not recorded
Sepsis · Respiratory Distress Syndrome
Enrolment: 18 · Results not recorded
Headache Disorders
Enrolment: 12 · Results not recorded
Critical COVID-19 With Respiratory Failure
Enrolment not recorded · Results not recorded
Healthy Volunteers · Headache · Migraine
Enrolment: 12 · Results not recorded
Headache · Migraine
Enrolment: 12 · Results not recorded
1 studies reported at therapy level; 1 evidence entries itemised.
Model: Severe acute pancreatitis (retrograde sodium taurocholate into bili-pancreatic duct)
Vasoactive intestinal peptide reduced endotoxaemia and intestinal inflammation and alleviated gut mucosal injury in severe acute pancreatitis in rats.
Extraction: extract · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.